USFDA approves Astellas' Veozah’ for treatment of vasomotor symptoms due to menopause
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause
This decision will accelerate growth for both its pharma & consumer healthcare businesses in India
The Awards recognizes standout digital health & medical technology products and companies
The committee voted that FDA should restrict use of LYNPARZA plus abi/pred to these BRCAm mCRPC patients
The partnership will capitalize on the combined capabilities of the two organizations
Specialty Chemicals grew 38% YoY for FY23
Cooperative agreement with U.S. Government to advance U.S. biopharma industry and ensure pandemic preparedness
The funding will be used to expand the product line for remote patient monitoring and to scale the business across Asia and Africa
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
Showcased digital innovations: MyPKFit, SYNAPSE and Athena at the G20 Health Working Group Meeting
Subscribe To Our Newsletter & Stay Updated